These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1341949)

  • 1. The N-myc proto-oncogene: developmental expression and in vivo site-directed mutagenesis.
    Stanton BR; Parada LF
    Brain Pathol; 1992 Jan; 2(1):71-83. PubMed ID: 1341949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype.
    Xu L; Meng Y; Wallen R; DePinho RA
    Oncogene; 1995 Nov; 11(9):1865-72. PubMed ID: 7478616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W; Schwab M
    Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of the N-myc gene in Wilms' tumors.
    Nisen PD; Zimmerman KA; Cotter SV; Gilbert F; Alt FW
    Cancer Res; 1986 Dec; 46(12 Pt 1):6217-22. PubMed ID: 2430692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
    Schuldiner O; Benvenisty N
    Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
    Haupt Y; Harris AW; Adams JM
    Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
    Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
    Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective development of the embryonic liver in N-myc-deficient mice.
    Giroux S; Charron J
    Dev Biol; 1998 Mar; 195(1):16-28. PubMed ID: 9520320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.
    Corrias MV; Cornaglia-Ferraris P; Di Martino D; Stenger AM; Lanino E; Boni L; Tonini GP
    Anticancer Res; 1990; 10(4):897-902. PubMed ID: 1974410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer.
    Camarero N; Mascaró C; Mayordomo C; Vilardell F; Haro D; Marrero PF
    Mol Cancer Res; 2006 Sep; 4(9):645-53. PubMed ID: 16940161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of N-myc in mice: what does the phenotype tell us?
    Davis A; Bradley A
    Bioessays; 1993 Apr; 15(4):273-5. PubMed ID: 8517856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of beta-galactosidase under the control of the human c-myc promoter in transgenic mice is inhibited by mithramycin.
    Jones DE; Cui DM; Miller DM
    Oncogene; 1995 Jun; 10(12):2323-30. PubMed ID: 7784080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.